Add Formweb to your mobile device
Following is a P and T Committee update (from the June 23rd meeting). Starting date for specific programs is 29 June 2015, unless otherwise noted. Please let me know if you have any questions or comments. Don’t forget to check the “New Drug Monitoring Spotlight” section of the website, which provides important monitoring information about newly approved drugs. Also, attached is the updated version of the “Not Stocked, Not Ordered” drug list with the new additions highlighted in red.
Below is the memo with links to the drug monographs, protocols, and formulary documents. Click to access the full P&T packet for this month, or here to access the P&T packet archive.
|
Drug or Drug Class |
Formulary Decision |
Comments |
| ivabradine (Corlanor) | Formulary status. | Oral drug for chronic heart failure, low inpatient use expected. |
| palbociclib (Ibrance) | Non-formulary, not stocked. | Oral drug for certain cases of advanced breast cancer, given with letrozole; available via specialty pharmacies only direct to patient, hospital cannot order. |
| suvorexant (Belsomra) | Formulary status, use restricted to patients admitted with it as a home medication. | This oral hypnotic drug is the first of a new pharmacological class called orexin receptor antagonists. If initially prescribed in the hospital, interchange to zolpidem unless “no sub” written. |
| tasimelteon (Hetlioz) | Non-formulary, not stocked, Rare use expected. | For rare sleep disorder in totally blind patients, distributed through specialty pharmacy programs directly to patient only, hospital cannot order. |
| liraglutide (Saxenda) | Non-formulary, not stocked, defer to outpatient setting. |
This drug is the same drug as Victoza that is used to treat diabetes. Saxenda is given SQ once daily for weight loss. Inpatient may use own supply if judged necessary. |
| human papillomavirus vaccine (Gardasil 9) | Non-formulary, not stocked, defer to outpatient setting (clinics/offices). | This is an expanded Gardasil with an additional 5 HPV types covered, Merck plans to phase out Gardasil in favor of Gardasil-9. |
| indomethacin (Tivorbex) | Non-formulary, not stocked. | This is an expensive indomethacin immediate release product in 20 mg and 40 mg caps, interchange to the 25 mg and 50 mg strengths, respectively. |
| memantine-donepezil (Namzaric) | Non-formulary, not stocked. | This is an expensive combination of generic memantine and donepezil, interchange to the two drugs separately. |
| DOXYcycline (Acticlate) | Non-formulary, not stocked. |
This is a doxycycline product in 2 different strengths with scored tabs, used for acne. Interchange to generic doxycycline in similar daily doses. |
| loxapine Inhalation (Adasuve) | Non-formulary, not stocked. | If ordered, contact MD for selection of another agent. |
| ketamine for ER Analgesia | Approved for use by ER physicians. | Can be used for stand alone or adjunctive use in ER with ER physician administering, dose of 0.2 – 0.5 mg/kg to maximum of 50 mg. Date of implementation TBA. |
| acetaminophen Intravenous (Ofirmev) | No change in restricted use. | Plan to develop methods of providing multimodal analgesia in coming months through a multidisciplinary team. |